According to recent filings covering the 90 days ending January 21, 2026, the three most significant insider holders at Quince Therapeutics are Director David Lamond (4.65Mn shares), Chief Scientific Officer Stephen S. Dominy (1.22Mn shares), Chief Executive Officer Casey Lynch (1.09Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| David Lamond | 4,649,836 | 14 Dec, 2023 | |
| Stephen S. Dominy | Chief Scientific Officer | 1,217,086 | 12 Nov, 2021 |
| Casey Lynch | Chief Executive Officer | 1,088,669 | 19 Nov, 2021 |
| Dirk Thye | Ceo And Cmo | 994,885 | 12 Dec, 2025 |
| Philip S Low | 519,283 | 23 May, 2022 | |
| Brendan Hannah | Cbo And Coo & Cco | 361,827 | 08 Dec, 2025 |
| Christopher P. Lowe | Interim Ceo And Coo & Cfo | 265,000 | 04 Mar, 2022 |
| Karen L. Smith | Chief Medical Officer | 194,690 | 27 May, 2022 |
| Leslie Holsinger | Evp And Preclinical Development | 148,080 | 08 Jun, 2022 |
| Michael J. Detke | Chief Medical Officer | 140,000 | 04 Mar, 2022 |
| Charles S. Ryan | President | 130,009 | 23 Jun, 2025 |
| Caryn Gordon Mcdowell | Chief Legal & Adm. Officer | 122,500 | 08 Jun, 2022 |
| Luca Benatti | 39,179 | 29 Dec, 2025 | |
| Ted Monohon | Chief Accounting Officer & Vp | 27,440 | 06 Mar, 2023 |
| Margaret Mcloughlin | 8,000 | 09 Aug, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 26 Dec, 2025 | Luca Benatti | Common Stock | D | 50,000 | $3.47 | 39,179 | D | S |
| 10 Dec, 2025 | Dirk Thye | Common Shares | D | 739,885 | $0.00 | 255,000 | D | G |
| 10 Dec, 2025 | Dirk Thye | Common Shares | A | 739,885 | $0.00 | 739,885 | I | G |
| 05 Dec, 2025 | Brendan Hannah | Common Shares | A | 25,280 | $0.94 | 361,827 | D | M |
| 05 Dec, 2025 | Brendan Hannah | Common Shares | A | 2,271 | $0.55 | 336,547 | D | M |
| 18 Jun, 2025 | Charles S. Ryan | Common Shares | A | 7,548 | $1.20 | 130,009 | D | A |
| 18 Jun, 2025 | Charles S. Ryan | - | - | 130,009 | D | |||
| 18 Jun, 2025 | Dirk Thye | Common Shares | A | 150,944 | $1.20 | 994,885 | D | A |
| 18 Jun, 2025 | Brendan Hannah | Common Shares | A | 37,736 | $1.20 | 334,276 | D | A |
| 30 Aug, 2024 | Dirk Thye | - | - | 843,941 | D | |||
| 30 Aug, 2024 | Dirk Thye | Common Stock | A | 77,000 | $0.70 | 843,941 | D | P |
| 29 Aug, 2024 | Dirk Thye | Common Stock | A | 77,500 | $0.69 | 766,941 | D | P |
| 29 Aug, 2024 | Dirk Thye | - | - | 766,941 | D | |||
| 21 Aug, 2024 | Brendan Hannah | - | - | 296,540 | D | |||
| 21 Aug, 2024 | Brendan Hannah | Common Stock | A | 23,565 | $0.63 | 296,540 | D | P |
| 21 Aug, 2024 | Brendan Hannah | Common Stock | A | 2,280 | $0.61 | 267,975 | D | P |
| 21 Aug, 2024 | Brendan Hannah | - | - | 272,975 | D | |||
| 21 Aug, 2024 | Brendan Hannah | - | - | 267,975 | D | |||
| 21 Aug, 2024 | Brendan Hannah | Common Stock | A | 5,000 | $0.62 | 272,975 | D | P |
| 20 Aug, 2024 | Charles S. Ryan | - | - | 122,461 | D |